z-logo
open-access-imgOpen Access
<p>Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry</p>
Author(s) -
Pierpaolo Di Micco,
Manuel Monreal
Publication year - 2020
Publication title -
journal of blood medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.676
H-Index - 18
ISSN - 1179-2736
DOI - 10.2147/jbm.s234053
Subject(s) - medicine , anticoagulant therapy , venous thromboembolism , platelet , anticoagulant , major bleeding , intensive care medicine , thrombosis , myocardial infarction
Major bleeding is one of the most dangerous complications for patients undergoing anticoagulant treatment for VTE. Several clinical scores have been planned to identify patients at higher risk of bleeding, and most of them take into consideration the number of platelets in particular if lower than normal. Here we report the clinical experience made with the RIETE registry concerning anticoagulant treatment in the presence of different values of platelets and their related risk of bleeding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here